Smith & Nephew (LON:SN) Stock Price Passes Above 200 Day Moving Average - Here's What Happened

Key Points

• Smith & Nephew's stock price has recently crossed above its 200-day moving average, indicating potential upward momentum, trading as high as GBX 1,356 ($18.28).
• Analysts have raised their price targets for Smith & Nephew, with JPMorgan increasing it to GBX 1,438 and Deutsche Bank to GBX 1,400, while the stock maintains a consensus rating of "Hold."
• Insider activity included acquisitions and sales, with notable transactions made by insiders, reflecting their ongoing engagement with the company's stock.

Smith & Nephew plc (LON:SN - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 1,165.88 ($15.72) and traded as high as GBX 1,356 ($18.28). Smith & Nephew shares last traded at GBX 1,353 ($18.24), with a volume of 2,724,153 shares.

Analyst Upgrades and Downgrades

SN has been the subject of several recent research reports. JPMorgan Chase & Co. upped their price objective on Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the company an "overweight" rating in a research note on Wednesday, August 6th. Berenberg Bank raised their price target on shares of Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the company a "hold" rating in a research note on Thursday, August 7th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the stock a "hold" rating in a report on Wednesday, August 6th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Smith & Nephew currently has an average rating of "Hold" and a consensus price target of GBX 1,379.33.

Smith & Nephew Price Performance

The stock has a market capitalization of £14.71 billion, a P/E ratio of 48.32, a PEG ratio of 0.46 and a beta of 0.62. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51. The business has a fifty day simple moving average of GBX 1,344.21 and a 200-day simple moving average of GBX 1,165.88.

Insider Buying and Selling at Smith & Nephew

In related news, insider Katarzyna Mazur Hofsaess acquired 541 shares of the company's stock in a transaction dated Friday, August 22nd. The shares were purchased at an average price of GBX 1,385 per share, for a total transaction of £7,492.85. Also, insider Deepak Nath sold 18,007 shares of the stock in a transaction dated Monday, August 18th. The stock was sold at an average price of GBX 1,351, for a total transaction of £243,274.57. Insiders purchased 4,811 shares of company stock valued at $12,947,701 over the last 90 days. Insiders own 0.19% of the company's stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.